Bradley Stringer MS, PhD

Dr. Stringer is currently an Associate Scientific Fellow at Takeda Pharmaceuticals based in Boston, MA. He began his career in 2001 at Millennium Pharmaceuticals in the Molecular Pathology department. For the past several years, Dr Stringer’s lab at Takeda has been focused on ADC target discovery and validation, including target tissue mapping, tissue cross reactivity, patient selection assays, pharmacodynamic assays and biomarker discovery. Dr Stringer received his PhD in 1993 from Oklahoma State University in the areas of biochemistry and cell biology. His post doctoral work includes an NIH fellowship at the Harvard T.H. Chan School of Public Health and the Brigham and Women’s/Faulkner hospital in Boston in the areas of immunology, cancer biology, and anatomic pathology.